A biotechnology company focused on discovering, developing and commercializing plant-based exosome formulas for regenerative beauty care applications
Cellestetix has raised €3.4M across 2 funding rounds from 13 investors, most recently a Seed round in Feb 2025. Based in Istanbul, Türkiye; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-02-27 | Seed | €1.6M | APY Ventures Bilişim Vadisi Fund,Arya GSYF,Leman Özgür Rodoplu,Lütfü Haluk Bayraktar,Maxis Ventures GSYF,Naci Topçuoğlu | View deal → |
| 2024-08-16 | Other | €1.8M | Ahmet Ramiz,Angel Investors,APY Ventures,Arya Ventures,İstcapital,Maxis Ventures+1 more | View deal → |
